OCS
Oculis Holding AG Ordinary shares
NASDAQ: OCS · HEALTHCARE · BIOTECHNOLOGY
$27.48
+3.89% today
Updated 2026-04-30
Market cap
$1.57B
P/E ratio
—
P/S ratio
1,311.54x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$16 – $31
Volume
0.4M
Oculis Holding AG Ordinary shares (OCS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-5,020.00%
ROE
-73.50%
ROA
-28.60%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $993000.00 | $-14.87M | -840.28% | -1,242.30% | -1,497.78% |
| 2021 | $960000.00 | $-18.55M | -896.67% | -1,378.33% | -1,932.50% |
| 2022 | $912000.00 | $-38.70M | -2,336.84% | -3,550.00% | -4,243.20% |
| 2023 | $883000.00 | $-88.80M | -3,212.23% | -9,140.88% | -10,056.85% |
| 2024 | $686000.00 | $-85.78M | -7,492.27% | -10,671.14% | -12,503.94% |
| 2025 | $0.00 | $-94.51M | — | — | — |